The idea that diabetic complications are linked to an increase in the activity of sorbitol dehydrogenase resulting in an increase in the intracellular concentration of NADH and an increase in the redox ratio of NADH-to-NAD
+ was first proposed in 1993 by Williamson et al.
1 Since that first report, several additional papers from their laboratory appear to support this redox hypothesis of diabetes, which the authors have termed “hyperglycemic pseudohypoxia.”
2 3 Williamson et al. have long argued that the ratio of NADH to NAD
+ in the cytoplasm of cells and tissues can be assessed on the basis of the near equilibrium between the concentration ratios of NADH/NAD
+ and lactate/pyruvate,
1 2 3 the latter measurements thus serving as surrogate measurements of the redox status in cells. However, data from other laboratories do not support the basic tenets of hyperglycemic pseudohypoxia.
4 5 6 7 8 9 Nonetheless, Williamson et al.
2 have argued against these reports (see the lengthy online appendix by Nyengaard et al. published in
Diabetes in 2004
3 ; http://diabetes.diabetesjournals.org). In the specific case of work published by our laboratory,
8 Ido and Williamson,
10 Williamson and Ido,
11 and Nyengaard et al.
3 argued that our experiments did not provide an independent test of the hyperglycemic pseudohypoxia hypothesis, because we did not measure the content of pyruvate in retinas incubated in media containing euglycemic and hyperglycemic concentrations of glucose. We had not measured pyruvate in that earlier study
8 because we thought that measurements of lactate alone provided us with sufficient information to question the redox hypothesis proposed by Williamson et al. Recently, the role of the sorbitol pathway in diabetic complications
12 13 14 has been pushed front and center in the medical literature—in part, as a result of a commentary that appeared in the “Medical News & Perspectives ” section of the
Journal of the American Medical Association.
15 This article included a statement that “the new work bolstering the sorbitol pathway’s role [i.e., hyperglycemic pseudohypoxia] in diabetic complications is biochemically sound but leaves some unanswered questions.” For this reason, we believed it important to follow the suggestion of Williamson et al.
3 10 11 and undertake additional, new experiments testing the soundness of the hypothesis of hyperglycemic pseudohypoxia by including measurements of both lactate and pyruvate in fresh retinas obtained from age-matched normal and experimental diabetic rats, to provide a more biologically relevant comparison for evaluating the hypothesis. To test the hypothesis further, we made measurements of these metabolites in retinas incubated in media containing 5, 10, or 30 mM glucose in the presence and absence of functioning mitochondria. The present results, when combined with our previous efforts,
8 provide the strongest evidence to date against the hyperglycemic pseudohypoxia hypothesis.